Stay updated on Immunotherapy with TIL in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov page. The study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T12:10:55.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:19:20.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T12:42:46.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    A new revision tag, Revision: v3.7.0, was added. Several core study documents and links, including the Informed Consent Form, Study Protocol and SAP, IPD sharing information, and publications, were removed from the record, reducing access to key materials and study context.
    Difference
    24%
    Check dated 2026-09-19T17:56:48.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a new build or documentation update on the page.
    Difference
    0.0%
    Check dated 2026-08-29T19:09:17.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a platform/software upgrade behind the page. The change does not modify the study details or visible content on the page.
    Difference
    0.0%
    Check dated 2026-08-08T20:12:46.000Z thumbnail image

Stay in the know with updates to Immunotherapy with TIL in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page.